Commentary on "A large-scale analysis of genetic variants within putative miRNA binding sites in prostate cancer." Stegeman S, Amankwah E, Klein K, O'Mara TA, Kim D, Lin HY, Permuth-Wey J, Sellers TA, Srinivasan S, Eeles R, Easton D, Kote-Jarai Z, Amin Al Olama A, Benlloch S, Muir K, Giles GG, Wiklund F, Gronberg H, Haiman CA, Schleutker J, Nordestgaard BG, Travis RC, Neal D, Pharoah P, Khaw KT, Stanford JL, Blot WJ, Thibodeau S, Maier C, Kibel AS, Cybulski C, Cannon-Albright L, Brenner H, Kaneva R, Teixeira MR, PRACTICAL Consortium, Australian Prostate Cancer BioResource, Spurdle AB, Clements JA, Park JY, Batra J, University of Washington-Urology, Seattle, WA. Cancer Discov 2015; 5(4):368-79.

Autor: Lin D; University of Washington-Urology, Seattle, WA. Electronic address: dlin@uw.edu.

Publikováno v: Urologic oncology [Urol Oncol] 2016 Nov; Vol. 34 (11), pp. 522-523.

Germline copy number variants and endometrial cancer risk.

Autor: Stylianou CE; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand., Wiggins GAR; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand. george.wiggins@otago.ac.nz., Lau VL; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand., Dennis J; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK., Shelling AN; Department of Obstetrics and Gynaecology, University of Auckland, Auckland, New Zealand., Wilson M; Te Pūriri o Te Ora Regional Cancer and Blood Service, Auckland Hospital, Auckland, New Zealand., Sykes P; Department of Obstetrics and Gynaecology, University of Otago, Christchurch, New Zealand., Amant F; Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, University Hospitals KU Leuven, University of Leuven, Leuven, Belgium.; Gynecological Oncology Laboratory, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium., Annibali D; Gynecological Oncology Laboratory, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium., De Wispelaere W; Gynecological Oncology Laboratory, Department of Oncology, KU Leuven and Leuven Cancer Institute (LKI), Leuven, Belgium., Easton DF; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.; Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK., Fasching PA; Department of Gynecology and Obstetrics, Comprehensive Cancer Center Erlangen-EMN, University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nuremberg, Erlangen, Germany., Glubb DM; Cancer Research Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Goode EL; Division of Epidemiology, Department of Quantitative Health Sciences, Mayo Clinic, Rochester, MN, USA., Lambrechts D; Laboratory for Translational Genetics, Department of Human Genetics, KU Leuven, Leuven, Belgium.; VIB Center for Cancer Biology, VIB, Leuven, Belgium., Pharoah PDP; Department of Computational Biomedicine, Cedars-Sinai Medical Center, West Hollywood, CA, USA., Scott RJ; Division of Molecular Medicine, Pathology North, John Hunter Hospital, Newcastle, NSW, Australia.; Faculty of Health, Discipline of Medical Genetics, School of Biomedical Sciences and Pharmacy, University of Newcastle, Callaghan, NSW, Australia.; Hunter Medical Research Institute, John Hunter Hospital, Newcastle, NSW, Australia., Tham E; Department of Molecular Medicine and Surgery, Karolinska Institutet, Stockholm, Sweden.; Clinical Genetics and Genomics, Karolinska University Hospital, Stockholm, Sweden., Tomlinson I; Department of Oncology, University of Oxford, Oxford, UK., Bolla MK; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK., Couch FJ; Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA., Czene K; Department of Medical Epidemiology and Biostatistics, Karolinska Institutet, Stockholm, Sweden., Dörk T; Gynaecology Research Unit, Hannover Medical School, Hannover, Germany., Dunning AM; Department of Oncology, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK., Fletcher O; The Breast Cancer Now Toby Robins Research Centre, The Institute of Cancer Research, London, UK., García-Closas M; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK., Hoppe R; Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology, Stuttgart, Germany.; University of Tübingen, Tübingen, Germany., Jernström H; Oncology, Department of Clinical Sciences in Lund, Lund University, Lund, Sweden., Kaaks R; Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany., Michailidou K; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK.; Biostatistics Unit, The Cyprus Institute of Neurology and Genetics, Nicosia, Cyprus., Obi N; Institute for Occupational and Maritime Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Institute for Medical Biometry and Epidemiology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Southey MC; Precision Medicine, School of Clinical Sciences at Monash Health, Monash University, Clayton, VIC, Australia.; Department of Clinical Pathology, The University of Melbourne, Melbourne, VIC, Australia.; Cancer Epidemiology Division, Cancer Council Victoria, Melbourne, VIC, Australia., Stone J; Genetic Epidemiology Group, School of Population and Global Health, University of Western Australia, Perth, WA, Australia.; Centre for Epidemiology and Biostatistics, Melbourne School of Population and Global Health, The University of Melbourne, Melbourne, VIC, Australia., Wang Q; Department of Public Health and Primary Care, Centre for Cancer Genetic Epidemiology, University of Cambridge, Cambridge, UK., Spurdle AB; Public Health Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., O'Mara TA; Cancer Research Program, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia., Pearson J; Department of Medicine, University of Otago, Christchurch, New Zealand., Walker LC; Department of Pathology and Biomedical Science, University of Otago, Christchurch, New Zealand.

Publikováno v: Human genetics [Hum Genet] 2024 Dec; Vol. 143 (12), pp. 1481-1498. Date of Electronic Publication: 2024 Nov 04.

Hypertension and Risk of Endometrial Cancer: A Pooled Analysis in the Epidemiology of Endometrial Cancer Consortium (E2C2).

Autor: Habeshian TS; Department of Population and Public Health Sciences, Keck School of Medicine of USC, University of Southern California, Los Angeles, California.; Department of Research and Evaluation, Division of Health Services Research and Implementation Science, Kaiser Permanente Southern California, Pasadena, California., Peeri NC; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., De Vivo I; Department of Epidemiology, Program in Genetic Epidemiology and Statistical Genetics, Harvard School of Public Health, Boston, Massachusetts.; Medicine, Harvard Medical School, Boston, Massachusetts., Schouten LJ; Department of Epidemiology, GROW-Research Institute for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands., Shu XO; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Cote ML; Fairbanks School of Public Health, Department of Epidemiology, Indiana University Simon Comprehensive Cancer Center, Indianapolis, Indiana., Bertrand KA; Slone Epidemiology Center, Boston University, Boston, Massachusetts., Chen Y; Population Health, New York University School of Medicine, New York, New York., Clarke MA; Division of Cancer Epidemiology and Genetics, NCI, Rockville, Maryland., Clendenen TV; Population Health, New York University School of Medicine, New York, New York., Cook LS; Epidemiology, Colorado School of Public Health, Aurora, Colorado., Costas L; Cancer Epidemiology Research Programme, Institut Català d'Oncologia, Barcelona, Spain.; Consortium for Biomedical Research in Epidemiology and Public Health - CIBERESP, Carlos III Institute of Health, Madrid, Spain., Dal Maso L; Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, Aviano, Italy., Freudenheim JL; Department of Epidemiology and Environmental Health, University at Buffalo, State University of New York, Buffalo, New York., Friedenreich CM; Department of Cancer Epidemiology and Prevention Research, Alberta Health Services, Calgary, Alberta, Canada., Gallagher G; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Gierach GL; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland., Goodman MT; Cancer Prevention and Control Program, Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, California., Jordan SJ; School of Public Health, University of Queensland, Herston, Queensland, Australia., La Vecchia C; Department of Clinical Medicine and Community Health, University of Milan, Milan, Italy., Lacey JV; Department of Computational and Quantitative Medicine, City of Hope, Duarte, California., Levi F; Epidemiology and Health Services Research, University of Lausanne, Lausanne, Switzerland., Liao LM; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland., Lipworth L; Department of Medicine, Vanderbilt University, Nashville, Tennessee., Lu L; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut., Matias-Guiu X; Department of Pathology, University Hospital of Bellvitge, IDIBELL, Barcelona, Spain., Moysich KB; Department of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, New York., Mutter GL; Pathology, Brigham and Women's Hospital, Boston, Massachusetts., Na R; Population Health, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Naduparambil J; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Negri E; Department of Medical and Surgical Sciences, University of Bologna, Bologna, Italy., O'Connell K; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., O'Mara TA; Cancer Research Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Onieva Hernández I; Faculty of Medicine, Cancer Epidemiology Research Programme and University of Barcelona, Institut Català d'Oncologia, Barcelona, Spain., Palmer JR; Slone Epidemiology Center and Department of Medicine, Boston University, Boston, Massachusetts., Parazzini F; Department of Clinical Medicine and Community Health, University of Milan, Milan, Italy., Patel AV; Population Science, American Cancer Society, Kennesaw, Georgia., Penney KL; Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Channing Division of Network Medicine, Department of Medicine, Brigham and Women's Hospital/Harvard Medical School, Boston, Massachusetts., Prizment AE; Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, Minnesota., Ricceri F; Department of Clinical and Biological Sciences, University of Turin, Orbassano, Italy., Risch HA; Department of Chronic Disease Epidemiology, Yale School of Public Health, New Haven, Connecticut., Sacerdote C; Unit of Cancer Epidemiology, Azienda Ospedaliera Citta' della Salute e della Scienza di Torino, Turin, Italy., Sandin S; Department of Medical Epidemiology and Biostatistics, Karolinska Institute, Stockholm, Sweden.; Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, New York., Stolzenberg-Solomon RZ; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland., van den Brandt PA; Epidemiology, Maastricht University, Maastricht, the Netherlands., Webb PM; Population Health Program, QIMR Berghofer Medical Research Institute, Herston, Queensland, Australia., Wentzensen N; Division of Cancer Epidemiology and Genetics, NCI, Rockville, Maryland., Wijayabahu AT; Division of Cancer Epidemiology and Genetics, NCI, Rockville, Maryland., Wilkens LR; Department of Epidemiology, University of Hawaii Cancer Center, Honolulu, Hawaii., Xu W; Epidemiology, Fudan University School of Public Health, Shanghai, China., Yu H; Cancer Center, University of Hawaii, Honolulu, Hawaii., Zeleniuch-Jacquotte A; Population health, New York University School of Medicine, New York, New York., Zheng W; Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee., Du M; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York., Setiawan VW; Department of Population and Public Health Sciences, Keck School of Medicine of USC, University of Southern California, Los Angeles, California.; Norris Comprehensive Cancer Center, University of Southern California, Los Angeles, California.

Publikováno v: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology [Cancer Epidemiol Biomarkers Prev] 2024 Jun 03; Vol. 33 (6), pp. 788-795.

Cigarette Smoking and Endometrial Cancer Risk:Observational and Mendelian Randomization Analyses

Autor: Dimou, N, Omiyale, W, Biessy, C, Viallon, V, Kaaks, R, O'Mara, TA, Aglago, EK, Ardanaz, E, Bergmann, MM, Bondonno, NP, Braaten, T, Colorado-Yohar, SM, Crous-Bou, M, Dahm, CC, Fortner, RT, Gram, IT, Harlid, S, Heath, AK, Idahl, A, Kvaskoff, M, Nøst, TH, Overvad, K, Palli, D, Perez-Cornago, A, Sacerdote, C, Sánchez, M-J, Schulze, MB, Severi, G, Simeon, V, Tagliabue, G, Tjønneland, A, Truong, T, Tumino, R, Johansson, M, Weiderpass, E, Murphy, N, Gunter, MJ, Lacey, B, Allen, NE, Dossus, L

Publikováno v: Dimou, N, Omiyale, W, Biessy, C, Viallon, V, Kaaks, R, O'Mara, T A, Aglago, E K, Ardanaz, E, Bergmann, M M, Bondonno, N P, Braaten, T, Colorado-Yohar, S M, Crous-Bou, M, Dahm, C C, Fortner, R T, Gram, I T, Harlid, S, Heath, A K, Idahl, A, Kvaskoff, M, Nøst, T H, Overvad, K, Palli, D, Perez-Cornago, A, Sacerdote, C, Sánchez, M-J, Schulze, M B, Severi, G, Simeon, V, Tagliabue, G, Tjønneland, A, Truong, T, Tumino, R, Johansson, M, Weiderpass, E, Murphy, N, Gunter, M J, Lacey, B, Allen, N E & Dossus, L 2022, ' Cigarette Smoking and Endometrial Cancer Risk : Observational and Mendelian Randomization Analyses ', Cancer Epidemiology, Biomarkers & Prevention, vol. 31, no. 9, pp. 1839-1848 . https://doi.org/10.1158/1055-9965.EPI-21-1176
Cancer Epidemiology, Biomarkers and Prevention
Dimou, N, Omiyale, W, Biessy, C, Viallon, V, Kaaks, R, O'Mara, T A, Aglago, E K, Ardanaz, E, Bergmann, M M, Bondonno, N P, Braaten, T, Colorado-Yohar, S M, Crous-Bou, M, Dahm, C C, Fortner, R T, Gram, I T, Harlid, S, Heath, A K, Idahl, A, Kvaskoff, M, Nost, T H, Overvad, K, Palli, D, Perez-Cornago, A, Sacerdote, C, Sanchez, M-J, Schulze, M B, Severi, G, Simeon, V, Tagliabue, G, Tjonneland, A, Truong, T, Tumino, R, Johansson, M, Weiderpass, E, Murphy, N, Gunter, M J, Lacey, B, Allen, N E & Dossus, L 2022, ' Cigarette Smoking and Endometrial Cancer Risk : Observational and Mendelian Randomization Analyses ', Cancer Epidemiology, Biomarkers & Prevention, vol. 31, no. 9, pp. 1839-1848 . https://doi.org/10.1158/1055-9965.EPI-21-1176
Cancer Epidemiol Biomarkers Prev
OF10
OF1

Background: Current epidemiologic evidence indicates that smoking is associated with a lower endometrial cancer risk. However, it is unknown if this association is causal or confounded. To further elucidate the role of smoking in endometrial cancer r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3532b3dd23f843a71cb8e9f00e5b726e
https://pure.au.dk/portal/da/publications/cigarette-smoking-and-endometrial-cancer-risk(c854712c-ba2e-4db7-acd0-28a0fcbc410b).html

Body size at different ages and risk of six cancers: a Mendelian randomization and prospective cohort study

Autor: Mariosa, D, Smith-Byrne, K, Richardson, TG, Ferrari, P, Gunter, MJ, Papadimitriou, N, Murphy, N, Christakoudi, S, Tsilidis, KK, Riboli, E, Muller, D, Purdue, MP, Chanock, SJ, Hung, RJ, Amos, CI, O'Mara, TA, Amiano, P, Pasanisi, F, Rodriguez-Barranco, M, Krogh, V, Tjønneland, A, Halkjær, J, Perez-Cornago, A, Chirlaque, M-D, Skeie, G, Rylander, C, Borch, KB, Aune, D, Heath, AK, Ward, HA, Schulze, M, Bonet, C, Weiderpass, E, Smith, GD, Brennan, P, Johansson, M

Publikováno v: Mariosa, D, Smith-Byrne, K, Richardson, T G, Ferrari, P, Gunter, M J, Papadimitriou, N, Murphy, N, Christakoudi, S, Tsilidis, K K, Riboli, E, Muller, D, Purdue, M P, Chanock, S J, Hung, R J, Amos, C I, O'Mara, T A, Amiano, P, Pasanisi, F, Rodriguez-Barranco, M, Krogh, V, Tjønneland, A, Halkjær, J, Perez-Cornago, A, Chirlaque, M-D, Skeie, G, Rylander, C, Borch, K B, Aune, D, Heath, A K, Ward, H A, Schulze, M, Bonet, C, Weiderpass, E, Smith, G D, Brennan, P & Johansson, M 2022, ' Body size at different ages and risk of six cancers : a Mendelian randomization and prospective cohort study ', Journal of the National Cancer Institute, vol. 114, no. 9, pp. 1296–1300 . https://doi.org/10.1093/jnci/djac061

It is unclear if body weight in early life affects cancer risk independently of adult body weight. To investigate this question for six obesity-related cancers, we performed univariable and multivariable analyses using i) Mendelian randomization (MR)

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c8dd0a4aaff2adab616e27bee872d54f
http://hdl.handle.net/11588/883178